Clinical Trials Browser

OTHER_GOV × Melanoma × pembrolizumab × Clear all

NCT07349303 2026-01-21

NEOPRIME

Phase 2 Recruiting

Melanoma

NCT05304546 2025-07-22

MK3475-C01

Phase 2 Completed

Melanoma, Neoplasms